Antivascular Endothelial Growth Factor Dosing Frequency and Visual Outcomes in Macular Edema Following Central Retinal Vein Occlusion.

J Vitreoretin Dis · 2021 · PMC9976151 · PMID 37007170

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

In the subset of eyes in the 4 subcohorts with both VA and central retinal thickness (CRT) measurements at baseline and all quarters of year 1, there appeared to be a slight trend toward improved vision and CRT with increasing injection frequency (Supplemental Figure 1).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.